Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Outpatient Day-Care Management of Unruptured Intracranial Aneurysm: A Retrospective Cohort Studyopen access

Authors
Suh, Dae ChulChoi, Yun HyeokPark, Sang IkYun, SuyoungJeong, So YeongJeong, SooKwon, BoseongSong, Yunsun
Issue Date
Aug-2022
Publisher
KOREAN SOCIETY OF RADIOLOGY
Keywords
Intracranial aneurysm; Coil embolization; Outcome; Neurointervention; Outpatient management
Citation
KOREAN JOURNAL OF RADIOLOGY, v.23, no.8, pp 828 - 834
Pages
7
Journal Title
KOREAN JOURNAL OF RADIOLOGY
Volume
23
Number
8
Start Page
828
End Page
834
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/72047
DOI
10.3348/kjr.2021.0940
ISSN
1229-6929
2005-8330
Abstract
Objective: This study aimed to assess the outcomes of outpatient day-care management of unruptured intracranial aneurysm (UIA), and to present the risks associated with different management strategies by comparing the outcomes and adverse events between outpatient day-care management and management with longer admission periods. Materials and Methods: This retrospective cohort study used prospectively registered data and was approved by a local institutional review board. We enrolled 956 UIAs from 811 consecutive patients (mean age +/- standard deviation, 57 +/- 10.7 years; male:female = 247:564) from 2017 to 2020. We compared the outcomes after embolization among the different admission-length groups (1, 2, and >= 3 days). The outcomes included pre-and post-modified Rankin Scale (mRS) scores and rates of adverse events, cure, recurrence, and reprocedure. Events were defined as any cerebrovascular problems, including minor and major stroke, death, or hemorrhage. Results: The mean admission period was 2 days, and 175 patients (191 aneurysms), 551 patients (664 aneurysms), and 85 patients (101 aneurysms) were discharged on the day of the procedure, day 2, and day 3 or later, respectively. During the mean 17-month follow-up period (range 6-53 months; 2757 patient years), no change in post-mRS was observed compared to pre-mRS in 99.6% of patients. Cure was achieved in 95.6% patients; minimal recurrence that did not require re-procedure occurred in 3.5% patients, and re-procedure was required in 2.3% (22 of 956) patients due to progressive enlargement of the recurrent sac during follow up (mean 17 months, range, 6-53 months). There were eight adverse events (0.8%), including five cerebrovascular (two major stroke, two minor strokes and one transient ischemic stroke), and three non-cerebrovascular events. Statistical comparison between groups with different admission lengths (1, 2, and >= 3 days) revealed no difference in the outcomes. Conclusion: This study revealed no difference in outcomes and adverse events according to the admission period, and suggested that UIA could be managed by outpatient day-care embolization.
Files in This Item
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE